An-Qiang Wang
Overview
Explore the profile of An-Qiang Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
141
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhou K, Li Z, Wu Y, Wang Z, Wang L, Zhou L, et al.
World J Gastroenterol
. 2025 Mar;
31(8):102347.
PMID: 40062330
Background: Gastric mixed-adenoneuroendocrine carcinoma (G-MANEC) is a subtype of gastric cancer. Building upon prior research findings, we propose that tumours containing both neuroendocrine carcinoma (NEC) and adenocarcinoma (AC) components, with...
2.
Lin J, Bai Y, Wang A, Long J, Xu W, Hu K, et al.
Hepatobiliary Pancreat Dis Int
. 2018 Aug;
17(5):381-382.
PMID: 30082196
No abstract available.
3.
Xie Y, Lin J, Wang A, Xu W, Long J, Luo Y, et al.
World J Gastroenterol
. 2017 Sep;
23(31):5787-5797.
PMID: 28883705
Aim: To detect the expression of threonine and tyrosine kinase (TTK) in gallbladder cancer (GBC) specimens and analyze the associations between TTK expression and clinicopathological parameters and clinical prognosis. Methods:...
4.
Lin J, Long J, Wang A, Zheng Y, Zhao H
World J Gastroenterol
. 2017 Aug;
23(28):5045-5050.
PMID: 28811702
Precision medicine, currently a hotspot in mainstream medicine, has been strongly promoted in recent years. With rapid technological development, such as next-generation sequencing, and fierce competition in molecular targeted drug...
5.
Xie Y, Jiang Y, Yang X, Wang A, Zheng Y, Wan X, et al.
World J Gastroenterol
. 2016 Dec;
22(46):10254-10259.
PMID: 28028375
Gallbladder cancer (GBC), although considered as a relatively rare malignancy, is the most common neoplasm of the biliary tract system. The late diagnosis and abysmal prognosis present challenges to treatment....
6.
Yang S, Wang A, Du J, Wang J, Yu W, Liu Q, et al.
World J Gastroenterol
. 2016 Jul;
22(25):5814-21.
PMID: 27433094
Aim: To investigate the relationship between ARID1A expression and clinicopathologic parameters, as well as its prognostic value, for patients with intrahepatic cholangiocarcinoma (IHCC). Methods: We assessed ARID1A protein and mRNA...
7.
Wang A, Zheng Y, Du J, Zhu C, Huang H, Wang S, et al.
World J Gastroenterol
. 2016 May;
22(18):4459-65.
PMID: 27182157
Combined hepatocellular cholangiocarcinoma (CHC) accounts for 0.4%-14.2% of primary liver cancer cases and possesses pathological features of both hepatocellular carcinoma and cholangiocarcinoma. Since this disease was first described and classified...
8.
Zhu C, Wang A, Zhang H, Wan X, Yang X, Chen S, et al.
World J Gastroenterol
. 2015 Nov;
21(42):12190-6.
PMID: 26576103
Liver cancer is a common malignancy and surgery is the main treatment strategy. However, the prognosis is still poor because of high frequencies of postoperative recurrence and metastasis. In recent...
9.
Wan X, Xu Y, Qian J, Yang X, Wang A, He L, et al.
World J Gastroenterol
. 2014 Jan;
19(46):8595-604.
PMID: 24379576
Intraductal papillary neoplasm of the bile duct (IPNB) is a variant of bile duct carcinoma that is characterized by intraductal growth and better outcomes compared with common cholangiocarcinoma. IPNBs are...